What Defines a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.
Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:
- Lexicon Pharmaceuticals LXRX - P/E: 4.94
- Opiant Pharmaceuticals OPNT - P/E: 4.86
- Bio-Rad Laboratories BIO - P/E: 7.83
- Five Star Senior Living FVE - P/E: 3.85
- Cronos Group CRON - P/E: 2.48
Lexicon Pharmaceuticals’s earnings per share for Q2 sits at -0.65, whereas in Q1, they were at -0.63. Lexicon Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Most recently, Opiant Pharmaceuticals reported earnings per share at -0.05, whereas in Q1 earnings per share sat at -0.4. Opiant Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Bio-Rad Laboratories has reported Q2 earnings per share at 1.61, which has decreased by 15.71% compared to Q1, which was 1.91. Bio-Rad Laboratories does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Most recently, Five Star Senior Living reported earnings per share at 0.1, whereas in Q1 earnings per share sat at -0.55. Five Star Senior Living does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Most recently, Cronos Group reported earnings per share at -0.19, whereas in Q1 earnings per share sat at 0.2. Cronos Group does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.